Zhang Lijin, Wu Bin, Zha Zhenlei, Zhao Hu, Yuan Jun, Feng Yejun
Department of Urology, Affiliated Jiang-yin Hospital of the Southeast University Medical College, Jiangyin, China.
Front Oncol. 2019 Jul 18;9:648. doi: 10.3389/fonc.2019.00648. eCollection 2019.
The aim of this study was to evaluate the correlation of various clinicopathological variables with positive surgical margins (PSMs) in renal cell cancer (RCC) patients after nephron-sparing surgery (NSS). A systematic search of PubMed, EMBASE, Web of Science, and China National Knowledge Infrastructure (CNKI) was performed to identify studies that compared PSMs with negative surgical margins (NSMs) and were published up to December 2018. Outcomes of interest included perioperative and postoperative variables, and the data were pooled by odds ratios (ORs)/standard mean differences (SMD) with 95% confidence intervals (CIs) to evaluate the strength of such associations. STATA 12.0 software was used for all statistical analyses. Based on the inclusion and exclusion criteria, 13 studies including 47,499 patients with RCC were analyzed. The results showed that higher Furhman grade (pooled OR = 1.25; 95% CI: 1.14-1.37; < 0.001), higher pathological stage (pooled OR = 2.67; 95% CI: 2.05-3.50; < 0.001), non-clear cell RCC (non-ccRCC) histology (pooled OR = 0.78; 95% CI: 0.72-0.84; < 0.001), and non-white race (pooled OR = 0.90; 95% CI: 0.82-0.99; = 0.026) were significantly associated with high risk of PSMs. However, age (pooled SMD = 0.09; 95% CI: -0.01-0.20; = 0.078), gender (female vs. male) (pooled OR = 1.04; 95% CI: 0.96-1.12; = 0.377), tumor laterality (left vs. right) (pooled OR = 1.09; 95% CI: 0.84-1.42; = 0.501), tumor focality (unifocal vs. multifocal) (pooled OR = 0.67; 95% CI: 0.23-1.90; = 0.445), tumor size (pooled SMD = 0.03; 95% CI: -0.10-0.15; = 0.685), and surgical approach (open vs. non-open) (pooled OR = 0.94; 95% CI: 0.62-1.42; = 0.763) had no relationship with PSMs. Sensitivity analysis showed that all models were stable, and no publication bias was observed in our study. The present findings demonstrate that the presence of PSMs was associated with higher Furhman grade and higher pathological stage. Additionally, non-white patients with non-ccRCC histology had a high risk of PSMs after NSS. Further multicenter and long-term follow-up studies are required to verify these findings.
本研究的目的是评估肾细胞癌(RCC)患者在保留肾单位手术(NSS)后,各种临床病理变量与手术切缘阳性(PSM)之间的相关性。我们对PubMed、EMBASE、Web of Science和中国知网(CNKI)进行了系统检索,以识别截至2018年12月发表的比较PSM与手术切缘阴性(NSM)的研究。感兴趣的结果包括围手术期和术后变量,并通过比值比(OR)/标准化均数差(SMD)及95%置信区间(CI)对数据进行合并,以评估这种关联的强度。所有统计分析均使用STATA 12.0软件。根据纳入和排除标准,分析了13项研究,共47499例RCC患者。结果显示,较高的富尔曼分级(合并OR = 1.25;95% CI:1.14 - 1.37;P < 0.001)、较高的病理分期(合并OR = 2.67;95% CI:2.05 - 3.50;P < 0.001)、非透明细胞RCC(non-ccRCC)组织学类型(合并OR = 0.78;95% CI:0.72 - 0.84;P < 0.001)以及非白种人(合并OR = 0.90;95% CI:0.82 - 0.99;P = 0.026)与PSM高风险显著相关。然而,年龄(合并SMD = 0.09;95% CI: - 0.01 - 0.20;P = 0.078)、性别(女性与男性)(合并OR = 1.04;95% CI:0.96 - 1.12;P = 0.377)、肿瘤位置(左侧与右侧)(合并OR = 1.09;95% CI:0.84 - 1.42;P = 0.501)、肿瘤灶性(单灶与多灶)(合并OR = 0.67;95% CI:0.23 - 1.90;P = 0.445)、肿瘤大小(合并SMD = 0.03;95% CI: - 0.10 - 0.15;P = 0.685)以及手术方式(开放与非开放)(合并OR = 0.94;95% CI:0.62 - 1.42;P = 0.763)与PSM均无关联。敏感性分析表明所有模型均稳定,且本研究未观察到发表偏倚。目前的研究结果表明,PSM的存在与较高的富尔曼分级和较高的病理分期相关。此外,具有non-ccRCC组织学类型的非白种患者在NSS后发生PSM的风险较高。需要进一步开展多中心和长期随访研究以验证这些发现。